---
schema_version: "secwatch.filing_event.v1"
accession: "0001548123-22-000151"
form_type: "8-K"
ticker: "NUMD"
cik: "0001543637"
company_name: "Nu-Med Plus, Inc."
filed_at: "2022-10-21T23:59:59+00:00"
generated_at: "2026-06-23T01:55:48.619902+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Nu-Med Plus appoints Jeffrey L. Robins to Board of Directors

## Summary
- On October 18, 2022, Board unanimously appointed Jeffrey L. Robins as an additional member.
- Appointment fills a recognized need for increased board membership.
- No other changes to officer positions or compensation disclosed.

## SEC filing metadata
- accession: 0001548123-22-000151
- form_type: 8-K
- ticker: NUMD
- cik: 0001543637
- company_name: Nu-Med Plus, Inc.
- filed_at: 2022-10-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1543637/000154812322000151/0001548123-22-000151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1543637/000154812322000151/form8k101822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001548123-22-000151
- JSON: https://secwatch.observer/filing/0001548123-22-000151.json
- Plain text: https://secwatch.observer/filing/0001548123-22-000151.txt

## Key facts
- Executive change
  Jeffrey L. Robins was appointed as Director at Nu-Med Plus, Inc..
  - Action: appointed
  - Role: Director
  source text: On October 18, 2022, the Board of Directors recognized the need for an additional member of the Board of Directors, and unanimously consented to appoint Jeffrey L. Robins to the Board of Director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1543637/000154812322000151/0001548123-22-000151-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.